UK fillip for Bracco as NICE voices resounding support for SonoVue
This article was originally published in Clinica
Executive Summary
Bracco Diagnostics’ SonoVue imaging agent has been thrust into mainstream UK liver care protocols after the National Institute for Heath and Clinical Excellence (NICE) issued a resoundingly positive appraisal of the ultrasound-enhancing technology’s capacity to diagnose and investigate primary and secondary cancers and cirrhosis.